View the public protocol
GlaxoSmithKline, Harvard Pilgrim Health Care Institute, CVS Health, Carelon Research, Humana HealthCare, HealthPartners Institute, University of Pennsylvania. Safety and effectiveness of RZV in adults ≥18 years of age with Systemic lupus erythematosus (SLE) or Multiple sclerosis (MS) (EPI-ZOSTER-041 VS US DB 215104) (EUPAS107073; Study ID 108331). Amsterdam: European Medicines Agency (EMA); 2023 Oct 18. Available from: https://catalogues.ema.europa.eu/node/3879/administrative-details
